Markus Richard 4
4 · Arcus Biosciences, Inc. · Filed Feb 11, 2025
Insider Transaction Report
Form 4
Markus Richard
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2025-02-10+305,328→ 305,328 totalExercise: $12.45Exp: 2035-01-30→ Common Stock (305,328 underlying) - Award
Common Stock
2025-02-10+75,193→ 75,193 total
Footnotes (2)
- [F1]Represents the grant of restricted stock units that vest in four equal annual installments beginning March 15, 2026, subject to the Reporting Person's continued service to the Company.
- [F2]The option becomes exercisable in 48 equal monthly installments after February 1, 2025, subject to the Reporting Person's continued service to the Company